Total Payments
$6,277
2024 Payments
$1,315
Companies
35
Transactions
435
Medicare Patients
3,393
Medicare Billing
$412,994
Payment Breakdown by Category
Food & Beverage$6,249 (99.5%)
Other$20.00 (0.3%)
Education$8.45 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,249 | 433 | 99.5% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $20.00 | 1 | 0.3% |
| Education | $8.45 | 1 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $2,071 | 150 | $0 (2024) |
| IRONWOOD PHARMACEUTICALS, INC | $579.02 | 36 | $0 (2024) |
| Janssen Biotech, Inc. | $551.78 | 38 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $481.75 | 35 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $451.13 | 34 | $0 (2024) |
| Allergan, Inc. | $263.40 | 19 | $0 (2020) |
| Braintree Laboratories, Inc. | $261.77 | 17 | $0 (2024) |
| PFIZER INC. | $237.88 | 16 | $0 (2024) |
| Daiichi Sankyo Inc. | $164.45 | 11 | $0 (2022) |
| Celgene Corporation | $122.63 | 8 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,315 | 79 | ABBVIE INC. ($493.85) |
| 2023 | $757.40 | 51 | ABBVIE INC. ($204.78) |
| 2022 | $977.40 | 72 | ABBVIE INC. ($393.61) |
| 2021 | $994.69 | 70 | AbbVie Inc. ($342.35) |
| 2020 | $267.94 | 19 | AbbVie Inc. ($44.97) |
| 2019 | $867.90 | 67 | AbbVie, Inc. ($227.66) |
| 2018 | $581.57 | 43 | AbbVie, Inc. ($182.42) |
| 2017 | $515.26 | 34 | AbbVie, Inc. ($181.06) |
All Payment Transactions
435 individual payment records from CMS Open Payments — Page 1 of 18
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $19.73 | General |
| Category: LIVER DISEASE | ||||||
| 12/16/2024 | ABBVIE INC. | CREON (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $20.00 | General |
| Category: ENDOCRINOLOGY | ||||||
| 12/11/2024 | SANOFI-AVENTIS U.S. LLC | REZUROCK (Drug) | Food and Beverage | In-kind items and services | $20.70 | General |
| Category: Oncology | ||||||
| 12/04/2024 | IRONWOOD PHARMACEUTICALS, INC | Linzess (Drug) | Food and Beverage | Cash or cash equivalent | $19.58 | General |
| Category: GI | ||||||
| 11/25/2024 | IRONWOOD PHARMACEUTICALS, INC | Linzess (Drug) | Food and Beverage | Cash or cash equivalent | $18.76 | General |
| Category: GI | ||||||
| 11/21/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $17.91 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 11/15/2024 | ABBVIE INC. | CREON (Drug), LINZESS | Food and Beverage | In-kind items and services | $14.00 | General |
| Category: ENDOCRINOLOGY | ||||||
| 11/13/2024 | Ferring Pharmaceuticals Inc. | REBYOTA (Biological) | Food and Beverage | In-kind items and services | $22.58 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/12/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $21.78 | General |
| Category: Immunology | ||||||
| 11/11/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $18.01 | General |
| Category: IMMUNOLOGY | ||||||
| 11/08/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $18.27 | General |
| Category: IMMUNOLOGY | ||||||
| 10/30/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $18.76 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 10/30/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $17.94 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/25/2024 | IRONWOOD PHARMACEUTICALS, INC | Linzess (Drug) | Food and Beverage | Cash or cash equivalent | $17.37 | General |
| Category: GI | ||||||
| 10/23/2024 | ABBVIE INC. | LINZESS (Drug) | Food and Beverage | In-kind items and services | $13.35 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/22/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $14.78 | General |
| Category: IMMUNOLOGY | ||||||
| 10/18/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $18.97 | General |
| Category: IMMUNOLOGY | ||||||
| 10/16/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $11.44 | General |
| Category: IMMUNOLOGY | ||||||
| 10/08/2024 | AIMMUNE THERAPEUTICS, INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $17.77 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 10/03/2024 | ABBVIE INC. | CREON (Drug) | Food and Beverage | In-kind items and services | $15.71 | General |
| Category: ENDOCRINOLOGY | ||||||
| 09/25/2024 | Ferring Pharmaceuticals Inc. | REBYOTA (Biological) | Food and Beverage | In-kind items and services | $19.64 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/20/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $13.82 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/18/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $5.43 | General |
| Category: IMMUNOLOGY | ||||||
| 09/17/2024 | Lilly USA, LLC | OMVOH (Drug) | Food and Beverage | In-kind items and services | $19.95 | General |
| Category: Immunology | ||||||
| 09/11/2024 | ABBVIE INC. | VIBERZI (Drug), CREON | Food and Beverage | In-kind items and services | $16.73 | General |
| Category: GASTROENTEROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 888 | 990 | $937,413 | $109,268 |
| 2022 | 13 | 948 | 1,079 | $875,764 | $117,333 |
| 2021 | 14 | 905 | 1,080 | $592,440 | $112,990 |
| 2020 | 12 | 652 | 842 | $437,070 | $73,403 |
Total Patients
3,393
Total Services
3,991
Medicare Billing
$412,994
Procedure Codes
51
All Medicare Procedures & Services
51 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 116 | 116 | $220,110 | $26,136 | 11.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 210 | 264 | $92,136 | $25,084 | 27.2% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 159 | 159 | $288,585 | $13,783 | 4.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 94 | 94 | $41,360 | $11,572 | 28.0% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 78 | 80 | $127,600 | $8,291 | 6.5% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 76 | 76 | $26,752 | $6,411 | 24.0% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 24 | 66 | $15,180 | $4,452 | 29.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 57 | 59 | $13,865 | $4,188 | 30.2% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2023 | 15 | 15 | $25,410 | $3,020 | 11.9% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2023 | 15 | 15 | $25,410 | $2,844 | 11.2% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 17 | 19 | $12,000 | $2,790 | 23.2% |
| 45381 | Injection beneath lining of large bowel using a flexible endoscope | Facility | 2023 | 27 | 27 | $49,005 | $696.52 | 1.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 251 | 327 | $71,841 | $30,983 | 43.1% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 118 | 118 | $229,705 | $25,962 | 11.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 135 | 135 | $34,680 | $16,898 | 48.7% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 166 | 166 | $300,705 | $14,948 | 5.0% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 75 | 77 | $105,730 | $7,818 | 7.4% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 32 | 84 | $19,995 | $4,762 | 23.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 64 | 64 | $15,271 | $4,084 | 26.7% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 23 | 23 | $8,901 | $3,738 | 42.0% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2022 | 15 | 15 | $26,788 | $3,021 | 11.3% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2022 | 11 | 11 | $19,588 | $2,211 | 11.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 13 | 13 | $3,030 | $1,699 | 56.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 17 | 18 | $2,855 | $843.39 | 29.5% |
| 45381 | Injection beneath lining of large bowel using a flexible endoscope | Facility | 2022 | 28 | 28 | $36,675 | $364.78 | 1.0% |
About Dr. William Ferges, M.D
Dr. William Ferges, M.D is a Gastroenterology healthcare provider based in Somerset, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/21/2011. The National Provider Identifier (NPI) number assigned to this provider is 1982909040.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. William Ferges, M.D has received a total of $6,277 in payments from pharmaceutical and medical device companies, with $1,315 received in 2024. These payments were reported across 435 transactions from 35 companies. The most common payment nature is "Food and Beverage" ($6,249).
As a Medicare-enrolled provider, Ferges has provided services to 3,393 Medicare beneficiaries, totaling 3,991 services with total Medicare billing of $412,994. Data is available for 4 years (2020–2023), covering 51 distinct procedure/service records.
Ad
Practice Information
- Specialty Gastroenterology
- Location Somerset, NJ
- Active Since 01/21/2011
- Last Updated 03/31/2015
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1982909040
Products in Payments
- STELARA (Biological) $551.78
- Linzess (Drug) $538.65
- XIFAXAN (Drug) $441.18
- RINVOQ (Biological) $337.33
- LINZESS (Drug) $323.14
- Humira (Biological) $310.57
- HUMIRA (Biological) $245.88
- XELJANZ (Drug) $237.88
- SKYRIZI (Biological) $234.02
- CREON (Drug) $202.54
- MAVYRET (Drug) $197.04
- VIBERZI (Drug) $187.00
- ZENPEP (Drug) $167.55
- ENTYVIO (Biological) $161.57
- SUTAB (Drug) $157.15
- Entyvio (Biological) $131.21
- Mavyret (Drug) $129.61
- Creon (Drug) $128.20
- INJECTAFER (Drug) $112.11
- ZEPOSIA (Drug) $109.35
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Somerset
Todd Horn, Md, MD
Gastroenterology — Payments: $21,360
Gastroenterology $21,360
Dr. Ira Merkel
Gastroenterology — Payments: $12,455
Gastroenterology $12,455
Scott Aronson, Md, MD
Gastroenterology — Payments: $8,282
Gastroenterology $8,282
Samir Cook, M.d, M.D
Gastroenterology — Payments: $7,719
Gastroenterology $7,719
Dr. Anna Platovsky, M.d, M.D
Gastroenterology — Payments: $5,768
Gastroenterology $5,768
Khalid Iqbal, Md, MD
Gastroenterology — Payments: $1,059
Gastroenterology $1,059